Berlex Laboratories, Inc.
Records under this name other than patents Berlex Laboratories, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Berlex Laboratories, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,692,763 | Methods for treating postmenopausal women using ultra-low doses of estrogen Formerly held Term ended Ended no later than Jul 11, 2020 · From the USPTO record | Term ended | Ended no later than Jul 11, 2020 | From the USPTO record |
| US 6,358,491 | Somatostatin analogs Formerly held Term ended Term ended Sep 16, 2019 · From the USPTO record | Term ended | Term ended Sep 16, 2019 | From the USPTO record |
| US 6,747,031 | N-heterocyclic derivatives as NOS inhibitors Lapsed on the fee record Ended Jun 8, 2016 · From the USPTO record | Lapsed on the fee record | Ended Jun 8, 2016 | From the USPTO record |
| US 7,351,397 | Stabilization of radiopharmaceutical compositions using hydrophilic 6-hydroxy chromans Formerly held Lapsed on the fee record Ended Apr 1, 2016 · From the USPTO record | Lapsed on the fee record | Ended Apr 1, 2016 | From the USPTO record |
| US 6,670,473 | N-heterocyclic derivatives as NOS inhibitors Lapsed on the fee record Ended Dec 30, 2015 · From the USPTO record | Lapsed on the fee record | Ended Dec 30, 2015 | From the USPTO record |
| US 6,432,947 | N-heterocyclic derivatives as NOS inhibitors Formerly held Lapsed on the fee record Ended Aug 13, 2014 · From the USPTO record | Lapsed on the fee record | Ended Aug 13, 2014 | From the USPTO record |
| US 6,989,138 | Stabilization of radiopharmaceutical compositions using hydrophilic thioethers and hydrophilic 6-hydroxy chromans Formerly held Lapsed on the fee record Ended Jan 24, 2014 · From the USPTO record | Lapsed on the fee record | Ended Jan 24, 2014 | From the USPTO record |
| US 6,274,091 | Apparatus and process for multiple chemical reactions Lapsed on the fee record Ended Aug 14, 2013 · From the USPTO record | Lapsed on the fee record | Ended Aug 14, 2013 | From the USPTO record |
| US 6,902,718 | Stabilization of radiopharmaceutical compositions using hydrophilic thioethers Formerly held Lapsed on the fee record Ended Jun 7, 2013 · From the USPTO record | Lapsed on the fee record | Ended Jun 7, 2013 | From the USPTO record |
| US 6,887,865 | N-heterocyclic derivatives as NOS inhibitors Lapsed on the fee record Ended May 3, 2013 · From the USPTO record | Lapsed on the fee record | Ended May 3, 2013 | From the USPTO record |